参芪降糖颗粒合吡格列酮二甲双胍对糖尿病合并代谢综合征的影响
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家青年科学基金项目(WJ2021Q069)


Effects of Shenqi Jiangtang Granules Combined with Pioglitazone Metformin on Diabetes Mellitus Complicated with Metabolic Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨吡格列酮二甲双胍联合参芪降糖颗粒治疗2型糖尿病合并代谢综合征患者的临床效果。方法:选取2020年3月至2021年7月德驭医疗马鞍山总医院收治的2型糖尿病合并代谢综合征患者60例作为研究对象,采用随机数字表法分为对照组和观察组,每组30例。对照组采取吡格列酮二甲双胍进行治疗,观察组在对照组治疗基础上增加参芪降糖颗粒治疗,比较2组患者的临床治疗有效率、血糖指标如空腹血糖(FBG)、餐后2 h血糖(2 hPBG)、糖化血红蛋白(HbA1c)、炎症介质如转化生长因子-β1(TGF-β1)、血清超敏C反应蛋白(hs-CRP)、血管细胞黏附分子-1(VCAM-1)、人颗粒蛋白前体(PGRN)、富含半胱氨酸的酸性分泌蛋白(SPARC),以及胰岛细胞功能胰岛素抵抗指数(HOMA-IR)、胰岛素分泌指数(HOMA-β)、空腹胰岛素(FINS)、血压、血脂、体质量及不良反应发生率等指标。结果:观察组的治疗有效率明显高于对照组(P<0.05);观察组患者FBG、2 hPBG、HbA1c等血糖指标明显低于对照组(P<0.05);观察组患者PGRN、TGF-β1、SPARC、VCAM-1、hs-CRP等炎症介质水平明显低于对照组(P<0.05);观察组患者FINS、HOMA-IR、HOMA-β等胰岛细胞功能指标优于对照组(P<0.05);观察组不良反应发生率明显低于对照组(P<0.05);观察组患者的体质量指数(BMI)、收缩压(SBP)、舒张压(DBP)、腰围(WC)等明显低于对照组(P<0.05);观察组患者低密度脂蛋白胆固醇(HDL-C)、三酰甘油(TG)、胆固醇(TC)等明显低于对照组(P<0.05)。结论:2型糖尿病合并代谢综合征患者采取吡格列酮二甲双胍联合参芪降糖颗粒治疗能够获得较为理想的效果,可更好改善患者的血糖水平,降低炎症介质水平,改善胰岛细胞功能,安全性较高,有着极大的推广价值。

    Abstract:

    To explore the effect of pioglitazone metformin combined with Shenqi Jiangtang Granules on type 2 diabetes mellitus patients with metabolic syndrome.Methods:A total of 60 patients with type 2 diabetes mellitus complicated with metabolic syndrome admitted to Deyu Medical Maanshan General Hospital from March 2020 to July were selected as the subjects and were divided into a control group(n=30) and an observation group(n=30) by random number.The control group was treated with pioglitazone metformin,and the observation group was additionally treated with Shenqi Jiangtang Granules on the basis of the control group.Glycated hemoglobin(HbA1c),inflammatory mediator transforming growth factor-β1(TGF-β1),serum high-sensitivity C-reactive protein(hs-CRP),vascular cell adhesion molecule-1(VCAM-1),human granulin precursor(PGRN),cysteine-rich acidic secretory protein(SPARC),islet cell function insulin resistance index(HOMA-IR),insulin secretion index(HOMA-β),fasting insulin(FINS),blood pressure,blood lipids,body mass and the incidence of adverse reactions and other indicators.Results:The total effective rate of the observation group was higher than the control group significantly(P<0.05); The blood glucose levels of FBG,2hPBGand HbA1c in the observation group were lower than those in the control group significantly(P<0.05); Compared with the control group,PGRN and TGF in the observation group-β 1.The levels of inflammatory factors such as SPARC,VCAM-1 and hs CRP were significantly lower(P<0.05); Fins,HOMA-IR and HOMA in control group and observation group-β There was significant difference in the function of islet cells(P<0.05); The incidence of adverse reactions in the observation group was lower than that in the control group significantly(P<0.05);The WC,BMI,SBP,DBP and other indicators of the observation group were significantly lower than those of the control group(P<0.05); the observation group's LDL-C,TG,TC and other parameters were significantly lower than the control group(P<0.05).Conclusion:Pioglitazone metformin combined with Shenqi Jiangtang Granules for treatment of patients with type 2 diabetes mellitus and metabolic syndrome can achieve ideal results,which can better improve the blood sugar level of patients,reduce the level of inflammatory mediators,and improve islet cell function,with high safety.It has great promotion value.

    参考文献
    相似文献
    引证文献
引用本文

郑谌,朱俊,何先凤,鲁佳,沈馨茹.参芪降糖颗粒合吡格列酮二甲双胍对糖尿病合并代谢综合征的影响[J].世界中医药,2022,(02).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-11-25
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-02-14
  • 出版日期:
文章二维码